Devices descending from K062440
16 later devices reach Gen-Probe Aptima Assay for Neisseria Gonorrhoeae, Model 1091 through their predicates, nearest generation first.
| Generation | Number | Device | Applicant | Decided | Own descendants | Recalls |
|---|---|---|---|---|---|---|
| +1 | K091724 | BD Probetec Chlamydia Trachomatis (CT) Q Amplified Dna Assay | Becton, Dickinson & CO | 2009 | 13 | — |
| +1 | K091730 | BD Probetec Neisseria Gonorrhoeae (GC) QX Amplified Dna Assay | Becton, Dickinson & CO | 2009 | 13 | 1 |
| +1 | K090827 | BD Probetec Neisseria Gonorrhoeae (GC) QX Amplified Dna Assay | Becton, Dickinson & CO | 2009 | 0 | 1 |
| +2 | K191352 | binx health io CT/NG Assay | Binx Health, Inc. | 2019 | 1 | — |
| +2 | K110923 | Cobas 4800 CT / NG Test | Roche Molecular Systems, Inc. | 2012 | 10 | 2 |
| +3 | K200533 | binx io CT/NG Assay and binx io CT/NG System | Binx Health, Inc. | 2020 | 0 | 1 |
| +3 | K163184 | cobas® CT/NG v2.0 Test | Roche Molecular Systems, Inc. | 2017 | 7 | — |
| +3 | K140887 | Cobas CT/NG V2.0 Test | Roche Molecular Systems, Inc. | 2014 | 0 | — |
| +3 | K132270 | Cobas CT/NG V2.0 Test | Roche Molecular Systems, Inc. | 2013 | 9 | — |
| +4 | K173887 | cobas CT/NG for use on cobas 6800/8800 systems | Roche Molecular Systems, Inc. | 2018 | 6 | — |
| +5 | K240217 | cobas® liat CT/NG nucleic acid test | Roche Molecular Systems, Inc. | 2025 | 0 | — |
| +5 | K240197 | cobas® liat CT/NG/MG nucleic acid test | Roche Molecular Systems, Inc. | 2025 | 0 | — |
| +5 | K202408 | cobas CTNG for use on cobas 6800/8800 systems | Roche Molecular Systems, Inc. | 2021 | 3 | — |
| +6 | K260917 | cobas CT/NG for use on the cobas 5800/6800/8800 systems; cobas TV/MG for use on the… | Roche Molecular Systems, Inc. | 2026 | 0 | — |
| +6 | K253759 | cobas liat CT/NG/MG nucleic acid test | Roche Molecular Systems, Inc. | 2026 | 0 | — |
| +6 | K253756 | cobas liat CT/NG nucleic acid test | Roche Molecular Systems, Inc. | 2026 | 0 | — |